Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 0.97x is 120% above its 5-year average of -4.92x, near the high end of its 5-year range (-16.40x–6.76x).
2789.10% above its 12-month average of 0.03x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -2.06x.
INTEREST COVERAGE RATIO
0.97x
INTEREST COVERAGE RATIO AVG TTM
0.03x
INTEREST COVERAGE RATIO AVG 3Y
-1.99x
INTEREST COVERAGE RATIO AVG 5Y
-4.92x
INTEREST COVERAGE RATIO AVG 10Y
-7.18x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+2789.10%
CURRENT VS 3Y AVG
+148.79%
CURRENT VS 5Y AVG
+119.72%
CURRENT VS 10Y AVG
+113.51%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+115.22%
vs the sector median at left
Akebia Therapeutics, Inc.
Market Cap
$237.84M
Interest Coverage Ratio
0.97x
TTM Avg
0.03x
3Y Avg
-1.99x
5Y Avg
-4.92x
Market Cap
$238.57M
Interest Coverage Ratio
-1.08x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.20x
Market Cap
$234.48M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$234.18M
Interest Coverage Ratio
N/A
TTM Avg
28.01x
3Y Avg
25.48x
5Y Avg
25.48x
Market Cap
$239.35M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.43M
Interest Coverage Ratio
N/A
TTM Avg
148.42x
3Y Avg
88.50x
5Y Avg
120.78x
Market Cap
$241.94M
Interest Coverage Ratio
0.57x
TTM Avg
0.57x
3Y Avg
0.57x
5Y Avg
0.57x
Market Cap
$242.28M
Interest Coverage Ratio
15.37x
TTM Avg
15.37x
3Y Avg
15.37x
5Y Avg
15.37x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. (AKBA) | $237.84M | 0.97x | 0.03x | -1.99x | -4.92x |
| High Tide Inc. (HITI)vs › | $238.57M | -1.08x | 0.39x | 0.39x | 0.20x |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $234.48M | N/A | N/A | N/A | N/A |
| SIGA Technologies, Inc. (SIGA)vs › | $234.18M | N/A | 28.01x | 25.48x | 25.48x |
| Invivyd, Inc. (IVVD)vs › | $237.22M | N/A | N/A | N/A | N/A |
| Quantum-Si incorporated (QSI)vs › | $239.35M | N/A | N/A | N/A | N/A |
| Utah Medical Products, Inc. (UTMD)vs › | $235.43M | N/A | 148.42x | 88.50x | 120.78x |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | 0.57x | 0.57x | 0.57x | 0.57x |
| Q32 Bio Inc. (QTTB)vs › | $242.28M | 15.37x | 15.37x | 15.37x | 15.37x |
| InflaRx N.V. (IFRX)vs › | $231.99M | -1280.37x | N/A | N/A | N/A |
Interest Coverage
1.0x
Debt/Equity
2.16
Current Ratio
1.43
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -2.06x |
| 2026-03-31 | 1.00x |
| 2025-12-31 | -1.77x |
| 2025-09-30 | 0.94x |
| 2025-06-30 | 2.06x |
| 2025-03-31 | 1.74x |
| 2024-12-31 | -2.08x |
| 2024-09-30 | -1.88x |
| 2024-06-30 | -4.06x |
| 2024-03-31 | -5.98x |
| 2023-12-31 | 0.97x |
| 2023-09-30 | -9.25x |
| 2023-06-30 | -5.48x |
| 2023-03-31 | -16.40x |
| 2022-12-31 | -3.88x |
| 2022-09-30 | -12.75x |
| 2022-06-30 | 6.76x |
| 2022-03-31 | -11.56x |
| 2021-12-31 | -12.85x |
| 2021-09-30 | -10.79x |
| 2021-06-30 | -15.99x |
| 2021-03-31 | -13.51x |
| 2020-12-31 | -36.86x |
| 2020-09-30 | -25.55x |
| 2020-06-30 | -75.31x |
| 2020-03-31 | -29.98x |
| 2019-12-31 | -120.12x |
| 2016-03-31 | -111.31x |
| 2015-12-31 | -125.31x |
| 2015-09-30 | -141.57x |
| 2015-06-30 | -93.87x |
| 2015-03-31 | -113.50x |
| 2014-12-31 | -130.95x |
| 2014-09-30 | -171.14x |
| 2014-06-30 | -155.43x |
| 2014-03-31 | -520.85x |
| 2013-12-31 | -319.14x |
| 2013-09-30 | -144.07x |
| 2013-03-31 | -3.42x |
